nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—ESR1—liver cancer	0.295	0.383	CbGaD
Clomifene—CYP2E1—liver cancer	0.239	0.311	CbGaD
Clomifene—CYP1A1—liver cancer	0.236	0.306	CbGaD
Clomifene—CYP1A2—Sorafenib—liver cancer	0.0071	0.308	CbGbCtD
Clomifene—ABCB1—Sorafenib—liver cancer	0.00621	0.269	CbGbCtD
Clomifene—Hepatocellular carcinoma—Sorafenib—liver cancer	0.00583	0.07	CcSEcCtD
Clomifene—Hepatic cancer—Sorafenib—liver cancer	0.00531	0.0637	CcSEcCtD
Clomifene—Heart malformation—Epirubicin—liver cancer	0.00418	0.0501	CcSEcCtD
Clomifene—Heart malformation—Doxorubicin—liver cancer	0.00387	0.0464	CcSEcCtD
Clomifene—ABCB1—Doxorubicin—liver cancer	0.00377	0.163	CbGbCtD
Clomifene—CYP3A4—Sorafenib—liver cancer	0.00372	0.161	CbGbCtD
Clomifene—Heart disease congenital—Epirubicin—liver cancer	0.00342	0.041	CcSEcCtD
Clomifene—Heart disease congenital—Doxorubicin—liver cancer	0.00316	0.0379	CcSEcCtD
Clomifene—Ascites—Sorafenib—liver cancer	0.00235	0.0281	CcSEcCtD
Clomifene—CYP3A4—Doxorubicin—liver cancer	0.00226	0.0979	CbGbCtD
Clomifene—Embolism—Sorafenib—liver cancer	0.00166	0.0199	CcSEcCtD
Clomifene—Leukaemia—Epirubicin—liver cancer	0.00146	0.0175	CcSEcCtD
Clomifene—Leukaemia—Doxorubicin—liver cancer	0.00135	0.0162	CcSEcCtD
Clomifene—Neoplasm—Sorafenib—liver cancer	0.000964	0.0116	CcSEcCtD
Clomifene—Ospemifene—ESR1—liver cancer	0.000944	0.302	CrCbGaD
Clomifene—Erythema nodosum—Epirubicin—liver cancer	0.000911	0.0109	CcSEcCtD
Clomifene—Ascites—Epirubicin—liver cancer	0.000867	0.0104	CcSEcCtD
Clomifene—Erythema nodosum—Doxorubicin—liver cancer	0.000843	0.0101	CcSEcCtD
Clomifene—Ascites—Doxorubicin—liver cancer	0.000802	0.00962	CcSEcCtD
Clomifene—Toremifene—ESR1—liver cancer	0.000769	0.246	CrCbGaD
Clomifene—Mood swings—Sorafenib—liver cancer	0.000733	0.00879	CcSEcCtD
Clomifene—Blindness—Epirubicin—liver cancer	0.000711	0.00853	CcSEcCtD
Clomifene—Blindness—Doxorubicin—liver cancer	0.000658	0.00789	CcSEcCtD
Clomifene—Pancreatitis—Sorafenib—liver cancer	0.000656	0.00786	CcSEcCtD
Clomifene—Transaminases increased—Epirubicin—liver cancer	0.000647	0.00776	CcSEcCtD
Clomifene—Abdominal discomfort—Sorafenib—liver cancer	0.000641	0.00769	CcSEcCtD
Clomifene—Optic neuritis—Epirubicin—liver cancer	0.00064	0.00768	CcSEcCtD
Clomifene—Toremifene—CYP1A1—liver cancer	0.000615	0.197	CrCbGaD
Clomifene—Embolism—Epirubicin—liver cancer	0.000614	0.00736	CcSEcCtD
Clomifene—Transaminases increased—Doxorubicin—liver cancer	0.000599	0.00718	CcSEcCtD
Clomifene—Optic neuritis—Doxorubicin—liver cancer	0.000592	0.0071	CcSEcCtD
Clomifene—Cyst—Epirubicin—liver cancer	0.000589	0.00706	CcSEcCtD
Clomifene—Renal failure—Sorafenib—liver cancer	0.000586	0.00703	CcSEcCtD
Clomifene—Jaundice—Sorafenib—liver cancer	0.000581	0.00697	CcSEcCtD
Clomifene—Embolism—Doxorubicin—liver cancer	0.000568	0.00681	CcSEcCtD
Clomifene—Thrombosis—Epirubicin—liver cancer	0.000556	0.00667	CcSEcCtD
Clomifene—Cyst—Doxorubicin—liver cancer	0.000545	0.00654	CcSEcCtD
Clomifene—Dermatitis atopic—Epirubicin—liver cancer	0.000532	0.00638	CcSEcCtD
Clomifene—Scotoma—Epirubicin—liver cancer	0.000519	0.00622	CcSEcCtD
Clomifene—Thrombosis—Doxorubicin—liver cancer	0.000515	0.00617	CcSEcCtD
Clomifene—Erythema multiforme—Sorafenib—liver cancer	0.000506	0.00607	CcSEcCtD
Clomifene—Tinnitus—Sorafenib—liver cancer	0.000499	0.00598	CcSEcCtD
Clomifene—Flushing—Sorafenib—liver cancer	0.000497	0.00596	CcSEcCtD
Clomifene—Dermatitis atopic—Doxorubicin—liver cancer	0.000492	0.0059	CcSEcCtD
Clomifene—Scotoma—Doxorubicin—liver cancer	0.00048	0.00575	CcSEcCtD
Clomifene—Arrhythmia—Sorafenib—liver cancer	0.000478	0.00573	CcSEcCtD
Clomifene—Alopecia—Sorafenib—liver cancer	0.000473	0.00567	CcSEcCtD
Clomifene—Erythema—Sorafenib—liver cancer	0.000466	0.00559	CcSEcCtD
Clomifene—Syncope—Sorafenib—liver cancer	0.000418	0.00501	CcSEcCtD
Clomifene—Loss of consciousness—Sorafenib—liver cancer	0.000409	0.00491	CcSEcCtD
Clomifene—Hypertension—Sorafenib—liver cancer	0.000402	0.00482	CcSEcCtD
Clomifene—Arthralgia—Sorafenib—liver cancer	0.000397	0.00476	CcSEcCtD
Clomifene—Myalgia—Sorafenib—liver cancer	0.000397	0.00476	CcSEcCtD
Clomifene—Hepatocellular injury—Epirubicin—liver cancer	0.000394	0.00472	CcSEcCtD
Clomifene—Pulmonary embolism—Epirubicin—liver cancer	0.000394	0.00472	CcSEcCtD
Clomifene—Shock—Sorafenib—liver cancer	0.000374	0.00449	CcSEcCtD
Clomifene—Pulmonary embolism—Doxorubicin—liver cancer	0.000364	0.00437	CcSEcCtD
Clomifene—Hepatocellular injury—Doxorubicin—liver cancer	0.000364	0.00437	CcSEcCtD
Clomifene—Neoplasm—Epirubicin—liver cancer	0.000356	0.00427	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000346	0.00415	CcSEcCtD
Clomifene—Mental disability—Epirubicin—liver cancer	0.000342	0.0041	CcSEcCtD
Clomifene—Dyspnoea—Sorafenib—liver cancer	0.000339	0.00406	CcSEcCtD
Clomifene—Phlebitis—Epirubicin—liver cancer	0.000332	0.00398	CcSEcCtD
Clomifene—Thrombophlebitis—Epirubicin—liver cancer	0.00033	0.00396	CcSEcCtD
Clomifene—Neoplasm—Doxorubicin—liver cancer	0.000329	0.00395	CcSEcCtD
Clomifene—Fatigue—Sorafenib—liver cancer	0.000328	0.00393	CcSEcCtD
Clomifene—Constipation—Sorafenib—liver cancer	0.000325	0.0039	CcSEcCtD
Clomifene—Pain—Sorafenib—liver cancer	0.000325	0.0039	CcSEcCtD
Clomifene—Eye pain—Epirubicin—liver cancer	0.000317	0.0038	CcSEcCtD
Clomifene—Mental disability—Doxorubicin—liver cancer	0.000316	0.00379	CcSEcCtD
Clomifene—Tamoxifen—ESR1—liver cancer	0.000307	0.0982	CrCbGaD
Clomifene—Phlebitis—Doxorubicin—liver cancer	0.000307	0.00368	CcSEcCtD
Clomifene—Hot flush—Epirubicin—liver cancer	0.000306	0.00366	CcSEcCtD
Clomifene—Thrombophlebitis—Doxorubicin—liver cancer	0.000306	0.00366	CcSEcCtD
Clomifene—Increased appetite—Epirubicin—liver cancer	0.000304	0.00365	CcSEcCtD
Clomifene—Menopausal symptoms—Epirubicin—liver cancer	0.000303	0.00363	CcSEcCtD
Clomifene—Urticaria—Sorafenib—liver cancer	0.000302	0.00362	CcSEcCtD
Clomifene—Body temperature increased—Sorafenib—liver cancer	0.000301	0.0036	CcSEcCtD
Clomifene—Eye pain—Doxorubicin—liver cancer	0.000293	0.00351	CcSEcCtD
Clomifene—Cerebrovascular accident—Epirubicin—liver cancer	0.000292	0.0035	CcSEcCtD
Clomifene—Diplopia—Epirubicin—liver cancer	0.000286	0.00343	CcSEcCtD
Clomifene—Hot flush—Doxorubicin—liver cancer	0.000283	0.00339	CcSEcCtD
Clomifene—Increased appetite—Doxorubicin—liver cancer	0.000282	0.00338	CcSEcCtD
Clomifene—Migraine—Epirubicin—liver cancer	0.000281	0.00337	CcSEcCtD
Clomifene—Affect lability—Epirubicin—liver cancer	0.000281	0.00337	CcSEcCtD
Clomifene—Menopausal symptoms—Doxorubicin—liver cancer	0.00028	0.00336	CcSEcCtD
Clomifene—Hypersensitivity—Sorafenib—liver cancer	0.00028	0.00336	CcSEcCtD
Clomifene—Asthenia—Sorafenib—liver cancer	0.000273	0.00327	CcSEcCtD
Clomifene—Mood swings—Epirubicin—liver cancer	0.000271	0.00325	CcSEcCtD
Clomifene—Cerebrovascular accident—Doxorubicin—liver cancer	0.00027	0.00324	CcSEcCtD
Clomifene—Pruritus—Sorafenib—liver cancer	0.000269	0.00323	CcSEcCtD
Clomifene—Diplopia—Doxorubicin—liver cancer	0.000265	0.00317	CcSEcCtD
Clomifene—Migraine—Doxorubicin—liver cancer	0.00026	0.00312	CcSEcCtD
Clomifene—Affect lability—Doxorubicin—liver cancer	0.00026	0.00312	CcSEcCtD
Clomifene—Diarrhoea—Sorafenib—liver cancer	0.00026	0.00312	CcSEcCtD
Clomifene—Dizziness—Sorafenib—liver cancer	0.000251	0.00301	CcSEcCtD
Clomifene—Mood swings—Doxorubicin—liver cancer	0.000251	0.003	CcSEcCtD
Clomifene—Tamoxifen—CYP2E1—liver cancer	0.000249	0.0796	CrCbGaD
Clomifene—Abdominal distension—Epirubicin—liver cancer	0.000249	0.00298	CcSEcCtD
Clomifene—Tamoxifen—CYP1A1—liver cancer	0.000246	0.0785	CrCbGaD
Clomifene—Pancreatitis—Epirubicin—liver cancer	0.000242	0.0029	CcSEcCtD
Clomifene—Vomiting—Sorafenib—liver cancer	0.000242	0.0029	CcSEcCtD
Clomifene—Rash—Sorafenib—liver cancer	0.00024	0.00287	CcSEcCtD
Clomifene—Dermatitis—Sorafenib—liver cancer	0.00024	0.00287	CcSEcCtD
Clomifene—Headache—Sorafenib—liver cancer	0.000238	0.00286	CcSEcCtD
Clomifene—Abdominal distension—Doxorubicin—liver cancer	0.00023	0.00276	CcSEcCtD
Clomifene—Pollakiuria—Epirubicin—liver cancer	0.000228	0.00274	CcSEcCtD
Clomifene—Nausea—Sorafenib—liver cancer	0.000226	0.00271	CcSEcCtD
Clomifene—Weight increased—Epirubicin—liver cancer	0.000225	0.0027	CcSEcCtD
Clomifene—Pancreatitis—Doxorubicin—liver cancer	0.000224	0.00269	CcSEcCtD
Clomifene—Renal failure—Epirubicin—liver cancer	0.000217	0.0026	CcSEcCtD
Clomifene—Jaundice—Epirubicin—liver cancer	0.000215	0.00257	CcSEcCtD
Clomifene—Pollakiuria—Doxorubicin—liver cancer	0.000211	0.00253	CcSEcCtD
Clomifene—Weight increased—Doxorubicin—liver cancer	0.000208	0.00249	CcSEcCtD
Clomifene—Renal failure—Doxorubicin—liver cancer	0.0002	0.0024	CcSEcCtD
Clomifene—Jaundice—Doxorubicin—liver cancer	0.000199	0.00238	CcSEcCtD
Clomifene—Hepatitis—Epirubicin—liver cancer	0.000198	0.00237	CcSEcCtD
Clomifene—Visual impairment—Epirubicin—liver cancer	0.000191	0.00229	CcSEcCtD
Clomifene—Erythema multiforme—Epirubicin—liver cancer	0.000187	0.00224	CcSEcCtD
Clomifene—Tinnitus—Epirubicin—liver cancer	0.000184	0.00221	CcSEcCtD
Clomifene—Flushing—Epirubicin—liver cancer	0.000184	0.0022	CcSEcCtD
Clomifene—Hepatitis—Doxorubicin—liver cancer	0.000183	0.00219	CcSEcCtD
Clomifene—Arrhythmia—Epirubicin—liver cancer	0.000177	0.00212	CcSEcCtD
Clomifene—Visual impairment—Doxorubicin—liver cancer	0.000176	0.00211	CcSEcCtD
Clomifene—Alopecia—Epirubicin—liver cancer	0.000175	0.0021	CcSEcCtD
Clomifene—Erythema multiforme—Doxorubicin—liver cancer	0.000173	0.00207	CcSEcCtD
Clomifene—Erythema—Epirubicin—liver cancer	0.000172	0.00206	CcSEcCtD
Clomifene—Tinnitus—Doxorubicin—liver cancer	0.000171	0.00205	CcSEcCtD
Clomifene—Flushing—Doxorubicin—liver cancer	0.00017	0.00204	CcSEcCtD
Clomifene—Flatulence—Epirubicin—liver cancer	0.00017	0.00203	CcSEcCtD
Clomifene—Tension—Epirubicin—liver cancer	0.000169	0.00203	CcSEcCtD
Clomifene—Nervousness—Epirubicin—liver cancer	0.000167	0.00201	CcSEcCtD
Clomifene—Back pain—Epirubicin—liver cancer	0.000167	0.002	CcSEcCtD
Clomifene—Arrhythmia—Doxorubicin—liver cancer	0.000163	0.00196	CcSEcCtD
Clomifene—Vision blurred—Epirubicin—liver cancer	0.000162	0.00195	CcSEcCtD
Clomifene—Alopecia—Doxorubicin—liver cancer	0.000162	0.00194	CcSEcCtD
Clomifene—Erythema—Doxorubicin—liver cancer	0.000159	0.00191	CcSEcCtD
Clomifene—Flatulence—Doxorubicin—liver cancer	0.000157	0.00188	CcSEcCtD
Clomifene—Tension—Doxorubicin—liver cancer	0.000156	0.00187	CcSEcCtD
Clomifene—Nervousness—Doxorubicin—liver cancer	0.000155	0.00186	CcSEcCtD
Clomifene—Vertigo—Epirubicin—liver cancer	0.000155	0.00185	CcSEcCtD
Clomifene—Syncope—Epirubicin—liver cancer	0.000154	0.00185	CcSEcCtD
Clomifene—Back pain—Doxorubicin—liver cancer	0.000154	0.00185	CcSEcCtD
Clomifene—Palpitations—Epirubicin—liver cancer	0.000152	0.00182	CcSEcCtD
Clomifene—Loss of consciousness—Epirubicin—liver cancer	0.000151	0.00181	CcSEcCtD
Clomifene—Vision blurred—Doxorubicin—liver cancer	0.00015	0.0018	CcSEcCtD
Clomifene—Convulsion—Epirubicin—liver cancer	0.000149	0.00179	CcSEcCtD
Clomifene—Hypertension—Epirubicin—liver cancer	0.000149	0.00178	CcSEcCtD
Clomifene—Myalgia—Epirubicin—liver cancer	0.000147	0.00176	CcSEcCtD
Clomifene—Arthralgia—Epirubicin—liver cancer	0.000147	0.00176	CcSEcCtD
Clomifene—Chest pain—Epirubicin—liver cancer	0.000147	0.00176	CcSEcCtD
Clomifene—Anxiety—Epirubicin—liver cancer	0.000146	0.00175	CcSEcCtD
Clomifene—Vertigo—Doxorubicin—liver cancer	0.000143	0.00172	CcSEcCtD
Clomifene—Syncope—Doxorubicin—liver cancer	0.000143	0.00171	CcSEcCtD
Clomifene—Palpitations—Doxorubicin—liver cancer	0.000141	0.00169	CcSEcCtD
Clomifene—Oedema—Epirubicin—liver cancer	0.000141	0.00168	CcSEcCtD
Clomifene—Loss of consciousness—Doxorubicin—liver cancer	0.00014	0.00168	CcSEcCtD
Clomifene—Shock—Epirubicin—liver cancer	0.000138	0.00166	CcSEcCtD
Clomifene—Convulsion—Doxorubicin—liver cancer	0.000138	0.00165	CcSEcCtD
Clomifene—Hypertension—Doxorubicin—liver cancer	0.000138	0.00165	CcSEcCtD
Clomifene—Tachycardia—Epirubicin—liver cancer	0.000137	0.00164	CcSEcCtD
Clomifene—Myalgia—Doxorubicin—liver cancer	0.000136	0.00163	CcSEcCtD
Clomifene—Chest pain—Doxorubicin—liver cancer	0.000136	0.00163	CcSEcCtD
Clomifene—Arthralgia—Doxorubicin—liver cancer	0.000136	0.00163	CcSEcCtD
Clomifene—Anxiety—Doxorubicin—liver cancer	0.000135	0.00162	CcSEcCtD
Clomifene—Oedema—Doxorubicin—liver cancer	0.00013	0.00156	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000128	0.00153	CcSEcCtD
Clomifene—Shock—Doxorubicin—liver cancer	0.000128	0.00153	CcSEcCtD
Clomifene—Insomnia—Epirubicin—liver cancer	0.000127	0.00152	CcSEcCtD
Clomifene—Tachycardia—Doxorubicin—liver cancer	0.000127	0.00152	CcSEcCtD
Clomifene—Paraesthesia—Epirubicin—liver cancer	0.000126	0.00151	CcSEcCtD
Clomifene—Dyspnoea—Epirubicin—liver cancer	0.000125	0.0015	CcSEcCtD
Clomifene—Fatigue—Epirubicin—liver cancer	0.000121	0.00145	CcSEcCtD
Clomifene—Pain—Epirubicin—liver cancer	0.00012	0.00144	CcSEcCtD
Clomifene—Constipation—Epirubicin—liver cancer	0.00012	0.00144	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000118	0.00142	CcSEcCtD
Clomifene—Insomnia—Doxorubicin—liver cancer	0.000118	0.00141	CcSEcCtD
Clomifene—Paraesthesia—Doxorubicin—liver cancer	0.000117	0.0014	CcSEcCtD
Clomifene—Dyspnoea—Doxorubicin—liver cancer	0.000116	0.00139	CcSEcCtD
Clomifene—Fatigue—Doxorubicin—liver cancer	0.000112	0.00134	CcSEcCtD
Clomifene—Urticaria—Epirubicin—liver cancer	0.000112	0.00134	CcSEcCtD
Clomifene—Constipation—Doxorubicin—liver cancer	0.000111	0.00133	CcSEcCtD
Clomifene—Pain—Doxorubicin—liver cancer	0.000111	0.00133	CcSEcCtD
Clomifene—Body temperature increased—Epirubicin—liver cancer	0.000111	0.00133	CcSEcCtD
Clomifene—Hypersensitivity—Epirubicin—liver cancer	0.000104	0.00124	CcSEcCtD
Clomifene—Urticaria—Doxorubicin—liver cancer	0.000103	0.00124	CcSEcCtD
Clomifene—Body temperature increased—Doxorubicin—liver cancer	0.000103	0.00123	CcSEcCtD
Clomifene—Asthenia—Epirubicin—liver cancer	0.000101	0.00121	CcSEcCtD
Clomifene—Pruritus—Epirubicin—liver cancer	9.94e-05	0.00119	CcSEcCtD
Clomifene—Diarrhoea—Epirubicin—liver cancer	9.61e-05	0.00115	CcSEcCtD
Clomifene—Hypersensitivity—Doxorubicin—liver cancer	9.58e-05	0.00115	CcSEcCtD
Clomifene—Asthenia—Doxorubicin—liver cancer	9.33e-05	0.00112	CcSEcCtD
Clomifene—Dizziness—Epirubicin—liver cancer	9.29e-05	0.00111	CcSEcCtD
Clomifene—Pruritus—Doxorubicin—liver cancer	9.2e-05	0.0011	CcSEcCtD
Clomifene—Vomiting—Epirubicin—liver cancer	8.93e-05	0.00107	CcSEcCtD
Clomifene—Diarrhoea—Doxorubicin—liver cancer	8.9e-05	0.00107	CcSEcCtD
Clomifene—Rash—Epirubicin—liver cancer	8.86e-05	0.00106	CcSEcCtD
Clomifene—Dermatitis—Epirubicin—liver cancer	8.85e-05	0.00106	CcSEcCtD
Clomifene—Headache—Epirubicin—liver cancer	8.8e-05	0.00106	CcSEcCtD
Clomifene—Dizziness—Doxorubicin—liver cancer	8.6e-05	0.00103	CcSEcCtD
Clomifene—Nausea—Epirubicin—liver cancer	8.35e-05	0.001	CcSEcCtD
Clomifene—Vomiting—Doxorubicin—liver cancer	8.27e-05	0.000991	CcSEcCtD
Clomifene—Rash—Doxorubicin—liver cancer	8.2e-05	0.000983	CcSEcCtD
Clomifene—Dermatitis—Doxorubicin—liver cancer	8.19e-05	0.000982	CcSEcCtD
Clomifene—Headache—Doxorubicin—liver cancer	8.14e-05	0.000977	CcSEcCtD
Clomifene—Nausea—Doxorubicin—liver cancer	7.72e-05	0.000926	CcSEcCtD
Clomifene—CYP1A1—Metabolism—ALDOB—liver cancer	1.74e-05	0.000145	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ADAM17—liver cancer	1.74e-05	0.000144	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PSMA4—liver cancer	1.74e-05	0.000144	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PSMD10—liver cancer	1.74e-05	0.000144	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—NR1H4—liver cancer	1.74e-05	0.000144	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—EPT1—liver cancer	1.72e-05	0.000143	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.71e-05	0.000142	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTA3—liver cancer	1.71e-05	0.000142	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—H2AFX—liver cancer	1.7e-05	0.000141	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CG—liver cancer	1.7e-05	0.000141	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GOT2—liver cancer	1.69e-05	0.00014	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CRABP1—liver cancer	1.66e-05	0.000138	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—GSTP1—liver cancer	1.65e-05	0.000137	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.64e-05	0.000136	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PPARG—liver cancer	1.64e-05	0.000136	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PSMD10—liver cancer	1.63e-05	0.000136	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PSMA4—liver cancer	1.63e-05	0.000136	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TAT—liver cancer	1.63e-05	0.000135	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—HMOX1—liver cancer	1.62e-05	0.000135	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP2E1—liver cancer	1.59e-05	0.000132	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.57e-05	0.000131	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.57e-05	0.00013	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTA4—liver cancer	1.56e-05	0.00013	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.56e-05	0.000129	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—HPGDS—liver cancer	1.54e-05	0.000128	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTA2—liver cancer	1.52e-05	0.000126	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—GSTM1—liver cancer	1.51e-05	0.000126	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PPARA—liver cancer	1.51e-05	0.000125	CbGpPWpGaD
Clomifene—EBP—Metabolism—AKT1—liver cancer	1.5e-05	0.000124	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.5e-05	0.000124	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CD—liver cancer	1.49e-05	0.000124	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYCS—liver cancer	1.49e-05	0.000123	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MYC—liver cancer	1.48e-05	0.000123	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ALB—liver cancer	1.47e-05	0.000122	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTA1—liver cancer	1.47e-05	0.000122	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.47e-05	0.000122	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GOT1—liver cancer	1.46e-05	0.000121	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GGT1—liver cancer	1.46e-05	0.000121	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.45e-05	0.000121	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—HPGDS—liver cancer	1.45e-05	0.000121	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—NAT2—liver cancer	1.45e-05	0.00012	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.44e-05	0.00012	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CPT1B—liver cancer	1.44e-05	0.000119	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GLUL—liver cancer	1.44e-05	0.000119	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CYP1A1—liver cancer	1.43e-05	0.000119	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MAPK14—liver cancer	1.39e-05	0.000116	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ALDOB—liver cancer	1.39e-05	0.000115	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NR1H4—liver cancer	1.39e-05	0.000115	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PSMA4—liver cancer	1.37e-05	0.000114	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PSMD10—liver cancer	1.37e-05	0.000114	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTA3—liver cancer	1.36e-05	0.000113	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—MTHFR—liver cancer	1.34e-05	0.000111	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.34e-05	0.000111	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GOT2—liver cancer	1.34e-05	0.000111	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CRABP1—liver cancer	1.33e-05	0.00011	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.33e-05	0.00011	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.32e-05	0.000109	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PPARA—liver cancer	1.31e-05	0.000109	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GSTP1—liver cancer	1.31e-05	0.000109	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CB—liver cancer	1.3e-05	0.000108	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.3e-05	0.000108	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PSMA4—liver cancer	1.29e-05	0.000107	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PSMD10—liver cancer	1.29e-05	0.000107	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.29e-05	0.000107	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—HMOX1—liver cancer	1.29e-05	0.000107	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PRKCE—liver cancer	1.27e-05	0.000105	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GOT2—liver cancer	1.26e-05	0.000104	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PPARG—liver cancer	1.25e-05	0.000104	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTA4—liver cancer	1.25e-05	0.000103	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.22e-05	0.000101	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTA2—liver cancer	1.21e-05	0.000101	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GSTM1—liver cancer	1.2e-05	9.99e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IGF2—liver cancer	1.2e-05	9.95e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP2E1—liver cancer	1.18e-05	9.82e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.18e-05	9.78e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYCS—liver cancer	1.17e-05	9.75e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTA1—liver cancer	1.17e-05	9.72e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—HPGDS—liver cancer	1.16e-05	9.62e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NAT2—liver cancer	1.16e-05	9.61e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GOT1—liver cancer	1.15e-05	9.57e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GGT1—liver cancer	1.15e-05	9.57e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.15e-05	9.51e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP1A1—liver cancer	1.14e-05	9.47e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—SERPINE1—liver cancer	1.12e-05	9.33e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CG—liver cancer	1.12e-05	9.32e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CSF2—liver cancer	1.12e-05	9.29e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.11e-05	9.24e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ALDOB—liver cancer	1.11e-05	9.21e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GLUL—liver cancer	1.11e-05	9.2e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CPT1B—liver cancer	1.11e-05	9.2e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYCS—liver cancer	1.11e-05	9.19e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—H2AFX—liver cancer	1.1e-05	9.16e-05	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.09e-05	9.06e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GOT1—liver cancer	1.09e-05	9.02e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GGT1—liver cancer	1.09e-05	9.02e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PPARG—liver cancer	1.08e-05	9e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NR1H4—liver cancer	1.07e-05	8.87e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—MTHFR—liver cancer	1.06e-05	8.83e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CRABP1—liver cancer	1.06e-05	8.79e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTA3—liver cancer	1.05e-05	8.72e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPARA—liver cancer	1.04e-05	8.66e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GSTP1—liver cancer	1.04e-05	8.59e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PSMA4—liver cancer	1.03e-05	8.58e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PSMD10—liver cancer	1.03e-05	8.58e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—HMOX1—liver cancer	1.02e-05	8.47e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GOT2—liver cancer	1.01e-05	8.34e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TERT—liver cancer	9.98e-06	8.28e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CD—liver cancer	9.88e-06	8.19e-05	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	9.86e-06	8.18e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GSTP1—liver cancer	9.76e-06	8.1e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ALB—liver cancer	9.75e-06	8.09e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—HMOX1—liver cancer	9.63e-06	7.99e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTA4—liver cancer	9.62e-06	7.98e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.54e-06	7.91e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GSTM1—liver cancer	9.52e-06	7.9e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP2E1—liver cancer	9.46e-06	7.85e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTA2—liver cancer	9.37e-06	7.78e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—HPGDS—liver cancer	9.26e-06	7.68e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.21e-06	7.64e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KDR—liver cancer	9.13e-06	7.57e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAPK14—liver cancer	9.07e-06	7.52e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTA1—liver cancer	9.04e-06	7.5e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP1A1—liver cancer	9.02e-06	7.49e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GSTM1—liver cancer	8.97e-06	7.44e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CG—liver cancer	8.94e-06	7.42e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NAT2—liver cancer	8.94e-06	7.42e-05	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	8.92e-06	7.4e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYCS—liver cancer	8.85e-06	7.34e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—F2—liver cancer	8.79e-06	7.29e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GGT1—liver cancer	8.68e-06	7.2e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GOT1—liver cancer	8.68e-06	7.2e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPARG—liver cancer	8.63e-06	7.16e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CB—liver cancer	8.61e-06	7.14e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ALDOB—liver cancer	8.57e-06	7.11e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—MTHFR—liver cancer	8.41e-06	6.98e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—APC—liver cancer	8.41e-06	6.98e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CG—liver cancer	8.41e-06	6.98e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.38e-06	6.96e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.28e-06	6.87e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PSMD10—liver cancer	8.25e-06	6.85e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PSMA4—liver cancer	8.25e-06	6.85e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPARA—liver cancer	8.25e-06	6.85e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CRABP1—liver cancer	8.18e-06	6.78e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GOT2—liver cancer	8.03e-06	6.66e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—MTHFR—liver cancer	7.93e-06	6.58e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CA—liver cancer	7.92e-06	6.57e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—BRAF—liver cancer	7.9e-06	6.56e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CD—liver cancer	7.86e-06	6.52e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTP1—liver cancer	7.8e-06	6.47e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPARA—liver cancer	7.78e-06	6.45e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ALB—liver cancer	7.76e-06	6.44e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—HMOX1—liver cancer	7.69e-06	6.38e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP2E1—liver cancer	7.55e-06	6.26e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CD—liver cancer	7.39e-06	6.13e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SERPINE1—liver cancer	7.31e-06	6.07e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.31e-06	6.06e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTM1—liver cancer	7.17e-06	5.95e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—HPGDS—liver cancer	7.15e-06	5.93e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MYC—liver cancer	7.12e-06	5.91e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CG—liver cancer	7.07e-06	5.86e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYCS—liver cancer	7.06e-06	5.86e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.99e-06	5.8e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GGT1—liver cancer	6.93e-06	5.75e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GOT1—liver cancer	6.93e-06	5.75e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CB—liver cancer	6.85e-06	5.69e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPARG—liver cancer	6.82e-06	5.66e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP1A1—liver cancer	6.79e-06	5.64e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CG—liver cancer	6.66e-06	5.53e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RAF1—liver cancer	6.6e-06	5.48e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AKT1—liver cancer	6.47e-06	5.37e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MTOR—liver cancer	6.44e-06	5.35e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CB—liver cancer	6.44e-06	5.35e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPARG—liver cancer	6.43e-06	5.34e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PSMA4—liver cancer	6.37e-06	5.29e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PSMD10—liver cancer	6.37e-06	5.29e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—MTHFR—liver cancer	6.33e-06	5.26e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTP1—liver cancer	6.23e-06	5.17e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPARA—liver cancer	6.21e-06	5.16e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CD—liver cancer	6.21e-06	5.15e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GOT2—liver cancer	6.2e-06	5.14e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—HMOX1—liver cancer	6.14e-06	5.09e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ALB—liver cancer	6.13e-06	5.09e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1B—liver cancer	6.05e-06	5.02e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CASP3—liver cancer	5.93e-06	4.92e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL2—liver cancer	5.92e-06	4.91e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CD—liver cancer	5.86e-06	4.86e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP2E1—liver cancer	5.83e-06	4.83e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ALB—liver cancer	5.78e-06	4.8e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—liver cancer	5.77e-06	4.79e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—JUN—liver cancer	5.76e-06	4.78e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTM1—liver cancer	5.72e-06	4.75e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNB1—liver cancer	5.71e-06	4.74e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MMP9—liver cancer	5.6e-06	4.65e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1A—liver cancer	5.58e-06	4.63e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYCS—liver cancer	5.45e-06	4.52e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAPK8—liver cancer	5.45e-06	4.52e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP1A1—liver cancer	5.42e-06	4.5e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CB—liver cancer	5.41e-06	4.49e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GOT1—liver cancer	5.35e-06	4.44e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GGT1—liver cancer	5.35e-06	4.44e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CG—liver cancer	5.32e-06	4.42e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CA—liver cancer	5.25e-06	4.35e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPARG—liver cancer	5.14e-06	4.26e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CB—liver cancer	5.1e-06	4.24e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—MTHFR—liver cancer	5.06e-06	4.2e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—liver cancer	5.03e-06	4.17e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—STAT3—liver cancer	4.98e-06	4.13e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPARA—liver cancer	4.96e-06	4.12e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—AKT1—liver cancer	4.94e-06	4.1e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTP1—liver cancer	4.8e-06	3.99e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—HMOX1—liver cancer	4.74e-06	3.93e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CD—liver cancer	4.68e-06	3.88e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MYC—liver cancer	4.63e-06	3.84e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ALB—liver cancer	4.62e-06	3.83e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TGFB1—liver cancer	4.62e-06	3.83e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.46e-06	3.7e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTM1—liver cancer	4.42e-06	3.66e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKT1—liver cancer	4.29e-06	3.56e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KRAS—liver cancer	4.28e-06	3.55e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CG—liver cancer	4.25e-06	3.52e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP1A1—liver cancer	4.19e-06	3.47e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CA—liver cancer	4.18e-06	3.47e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPARG—liver cancer	4.1e-06	3.4e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CB—liver cancer	4.08e-06	3.38e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CA—liver cancer	3.93e-06	3.26e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—MTHFR—liver cancer	3.9e-06	3.24e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPARA—liver cancer	3.83e-06	3.18e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—liver cancer	3.8e-06	3.15e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CD—liver cancer	3.73e-06	3.1e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ALB—liver cancer	3.69e-06	3.06e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HRAS—liver cancer	3.63e-06	3.02e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL6—liver cancer	3.48e-06	2.89e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKT1—liver cancer	3.41e-06	2.83e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CA—liver cancer	3.3e-06	2.74e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CG—liver cancer	3.28e-06	2.72e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CB—liver cancer	3.25e-06	2.7e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKT1—liver cancer	3.21e-06	2.66e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPARG—liver cancer	3.16e-06	2.63e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CA—liver cancer	3.11e-06	2.58e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CD—liver cancer	2.88e-06	2.39e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ALB—liver cancer	2.85e-06	2.36e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKT1—liver cancer	2.7e-06	2.24e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKT1—liver cancer	2.54e-06	2.11e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CB—liver cancer	2.51e-06	2.08e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CA—liver cancer	2.49e-06	2.06e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKT1—liver cancer	2.03e-06	1.68e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CA—liver cancer	1.98e-06	1.65e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKT1—liver cancer	1.62e-06	1.34e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CA—liver cancer	1.53e-06	1.27e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKT1—liver cancer	1.25e-06	1.04e-05	CbGpPWpGaD
